RE: Roche scoops up COVID test maker for $1.8B15 Mar 2021 09:42
B2 on following grimtims link
Total revenue of $171.6 million, an increase of 95% over 2019
ePlex® revenue of $152.6 million, an increase of 155% over 2019
Gross margin of 40%, compared to 32% in 2019
Cash and investments were $128.2 million as of December 31, 2020
Delivered $6.1 million in positive cash flows from operating activities
Now is e-Plex an all rounder as the bulk of there revenues are from it, quick look brings up this,
https://www.fda.gov/media/136282/download
Starts to go above my head now
but may be a better comparison than I initially thought. 40% profit fair play massive reinvestment 120+mil dollars.